Literature DB >> 3600920

How far since Ellis? The Manchester Study of glomerular disease.

N P Mallick, C D Short, L P Hunt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3600920     DOI： 10.1159/000184325

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

Review 1.  Renoprotective therapy in patients with nondiabetic nephropathies.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Authors:  Giuseppe Remuzzi; Ariela Benigni; Andrea Remuzzi
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 3.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

4.  Long-term prognosis of chronic glomerulonephritis.

Authors:  S I Ryabov; V V Stavskaya
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

5.  Role of remission clinics in the longitudinal treatment of CKD.

Authors:  Piero Ruggenenti; Elena Perticucci; Paolo Cravedi; Vincenzo Gambara; Marco Costantini; Sanjib Kumar Sharma; Annalisa Perna; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

6.  Renal diseases in Kuwait. Experience with 244 renal biopsies.

Authors:  S H Abu-Romeh; J van der Meulen; M C Cozma; N al-Tamimi; J H Ali; G Cozma; M S Adnani; K V Johny
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

7.  Tamm-Horsfall protein determination in Balkan endemic nephropathy.

Authors:  M Radonić; D Cvorisćec; G Borso; A Stavljenić; S Ceović
Journal:  Urol Res       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.